2011•Leukemia ResearchRequires access

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia

Steven Trifilio, Alfred Rademaker, Diane Newman, Katherine Coyle, Katrin M. Carlson-Leuer, Jayesh Mehta, Jessica K. Altman, Olga Frankfurt, Martin S. Tallman

Open publisher page 34 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 34 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mitoxantrone, Cytarabine, Etoposide, Medicine, Myeloid leukemia, Internal medicine, Oncology, Salvage therapy

Back to paper search Browse research topics Original source

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia — Research Paper | ScholarLens